Osteoarthritis Treatment Market Size, Share, Trends, Growth, and Regional Forecast, 2025 to 2032

Osteoarthritis Treatment Market by Treatment Type (Drugs and Assistive Devices), Indication (Knee Osteoarthritis, Spine Osteoarthritis, Hip Osteoarthritis, Foot & Ankle Osteoarthritis, and Others), End- User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, and Others), and Regional Analysis from 2025 to 2032

ID: PMRREP4458| 197 Pages | 30 Oct 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Osteoarthritis Treatment Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Treatment Type Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Osteoarthritis Treatment Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
    3. Global Osteoarthritis Treatment Market Outlook: Treatment Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Treatment Type, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2025 - 2032
        1. Drugs
          1. Viscosupplementation Agents
          2. Analgesics
          3. Others
        2. Assistive Devices
      4. Market Attractiveness Analysis: By Treatment Type
    4. Global Osteoarthritis Treatment Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
        1. Knee Osteoarthritis
        2. Spine Osteoarthritis
        3. Hip Osteoarthritis
        4. Foot & Ankle Osteoarthritis
        5. Others
      4. Market Attractiveness Analysis: Indication
    5. Global Osteoarthritis Treatment Market Outlook: End-use
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
      4. Market Attractiveness Analysis: End-use
  5. Global Osteoarthritis Treatment Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2024
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Osteoarthritis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End-use
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drugs
        1. Viscosupplementation Agents
        2. Analgesics
        3. Others
      2. Assistive Devices
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Knee Osteoarthritis
      2. Spine Osteoarthritis
      3. Hip Osteoarthritis
      4. Foot & Ankle Osteoarthritis
      5. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    7. Market Attractiveness Analysis
  7. Europe Osteoarthritis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End-use
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drugs
        1. Viscosupplementation Agents
        2. Analgesics
        3. Others
      2. Assistive Devices
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Knee Osteoarthritis
      2. Spine Osteoarthritis
      3. Hip Osteoarthritis
      4. Foot & Ankle Osteoarthritis
      5. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    7. Market Attractiveness Analysis
  8. East Asia Osteoarthritis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End-use
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drugs
        1. Viscosupplementation Agents
        2. Analgesics
        3. Others
      2. Assistive Devices
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Knee Osteoarthritis
      2. Spine Osteoarthritis
      3. Hip Osteoarthritis
      4. Foot & Ankle Osteoarthritis
      5. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Osteoarthritis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End-use
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drugs
        1. Viscosupplementation Agents
        2. Analgesics
        3. Others
      2. Assistive Devices
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Knee Osteoarthritis
      2. Spine Osteoarthritis
      3. Hip Osteoarthritis
      4. Foot & Ankle Osteoarthritis
      5. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    7. Market Attractiveness Analysis
  10. Latin America Osteoarthritis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End-use
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drugs
        1. Viscosupplementation Agents
        2. Analgesics
        3. Others
      2. Assistive Devices
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Knee Osteoarthritis
      2. Spine Osteoarthritis
      3. Hip Osteoarthritis
      4. Foot & Ankle Osteoarthritis
      5. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    7. Market Attractiveness Analysis
  11. Middle East & Africa Osteoarthritis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End-use
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drugs
        1. Viscosupplementation Agents
        2. Analgesics
        3. Others
      2. Assistive Devices
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Knee Osteoarthritis
      2. Spine Osteoarthritis
      3. Hip Osteoarthritis
      4. Foot & Ankle Osteoarthritis
      5. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025 - 2032
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. ABIOGEN PHARMA S.p.A
        1. Overview
        2. Segments and Treatment Types
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Assertio Holdings, Inc.
      3. Abbott
      4. Bayer AG
      5. Johnson & Johnson
      6. Merck KGaA
      7. Viatris Inc.
      8. Eli Lilly and Company
      9. Pfizer Inc.
      10. Reckitt Benckiser Group PLC
      11. Sanofi
      12. Teva Pharmaceutical Industries Ltd.
      13. Zimmer Biomet
      14. Apotex Inc.
      15. Samil Pharmaceutical Co., Ltd
      16. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate